IP Library Assignment 038643/0790
Patent Assignment
Reel/Frame 038643/0790

Assignment of Assignor's Interest

Recorded: 2016-05-19 Pages: 12
Assignor
ALNYLAM PHARMACEUTICALS, INC.
Executed: 2012-12-05
Assignee
TEKMIRA PHARMACEUTICALS CORPORATION
100-8900 GLENLYON PARKWAY, BURNABY, BRITISH COLUMBIA, V5J 5J8, CANADA
Covered Property (1)
Site-Specific Delivery of Nucleic Acids by Combining Targeting Ligands with Endosomolytic Components
Patent: 9,895,448 →
Application: 15/133,010 →
Publication: US 2016/0367687
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 23, 2017
From: MANOHARAN, MUTHIAH; RAJEEV, KALLANTHOTTATHIL G.; BUTLER, DAVID; JAYARAMAN, MUTHUSAMY
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 042802/0370 →
Change of Name Jun 23, 2017
From: TEKMIRA PHARMACEUTICALS CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 042802/0375 →
Merger and Change of Name Jul 27, 2018
From: PROTIVA BIOTHERAPEUTICS INC.; ARBUTUS BIOPHARMA CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 046640/0764 →